[13] Meanwhile, in respect to the cardiovascular effects of GLP-1RAs, since several cardiovascular outcome trials (CVOTs) have demonstrated that the cardio-protective effects of GLP-1RAs were independent with glycemic control or weight loss [14-16], GLP-1RAs have been proved with specific cardiovascular benefits
Yet you're still exhausted, your periods are chaos, and the weight won't budge
But if insurance denies coverage, you're looking at the membership fee plus retail medication cost, pushing your total well above $500/month
The weekly semaglutide injections reduced heart attack, stroke, and cardiovascular death by about 20% compared to placebo
Who Is Retatrutide Best For
Indeed, phase 3 clinical trials of retatrutide for type 2 diabetes, non-alcoholic fatty liver disease, and obesity are presently underway (Supplementary Table S2) 10